PharmaConnect Africa Conference & Expo
Theme - Access to Essential Medicines for Africa
Conference Completed
Midrand Conference Centre, Johannesburg, South Africa
Presentations
Day 1 - Clinical Trials in Africa
Ms Bisola Ashiru (Novartis) – Plenary
Innovation in Drug Development Clinical Trials in Africa
Download PresentationMs Delese Mimi Darko (Food and Drug Authority (FDA) Ghana)
Towards Priority Reviews for Essential Medicines
Download PresentationDay 1 - Regulatory Harmonization or Convergence
Dr Mercè Caturla (Janssen Pharmaceutica NV)
Stringent Regulatory Authority Collaborative Registration Procedure
Download PresentationMr John Patrick Mwesigye (East African Community (EAC))
East African Community Medicines Regulatory Harmonization Project
Download PresentationMs Lesley Wentworth (Southern Africa Business Forum)
Southern Africa Business Forum Pharmaceuticals Working Group
Download PresentationMr Abraham Gebregiorgis Kahsay (World Health Organization HQ)
WHO's role in Medicine Regulatory harmonization
Download PresentationDay 2 - Education & Training
Prof Norman Nyazema (University of Limpopo)
Education & Training needs & the Key Challenges in the Pharmaceutical Industry in SA
Download PresentationProf Gill Enslin (Tshwane University of Technology)
East African Community Medicines Regulatory Harmonization Project
Download PresentationDay 2 - Local Pharmaceutical Production
Mr David Woo & Mr Abraham Gebregiorgis Kahsay (World Health Organization (WHO) HQ)
Improving Access through Local Production and Related Technology Transfer of Health Products
Download PresentationMr Juergen Reinhardt (United Nations Industrial Development Organization (UNIDO) HQ)
Strengthening the local production of essential medicines in developing and least developed countries
Download PresentationDr Eugenia Barros (The Council for Scientific and Industrial Research (CSIR))
Production of recombinant therapeutic proteins opportunities, challenges and possible – solutions
Download PresentationMr Emmanuel Mujuru (Plus5 Pty Ltd, Zimbabwe)
Access To Essential Medicines In Africa
Download Presentation
Main Sponsors
Sponsorship Opportunities
About This Conference
The World Health Organization (WHO) introduced the concept of essential medicines in 1977. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality, and at a price the individual and the community can afford. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. In Africa, many countries have adopted the Essential Medicines List concept and embraced the principles of rational use of medicines. However there are critical challenges which this 2 day conference and exposition will seek to address. The areas of focus of PharmaConnect Africa (PharmaConnect-A) 2017 will be local pharmaceutical manufacturing, offshore procurement and distribution, and the over-arching role of medicine regulation along the whole value chain.
Read MoreThemes and Topics
Themes and Topics to be covered will include:
Clinical trials in Africa
Some regulators have started to give priority reviews to essential medicines in registration. However this is not matched with priority approvals of clinical trials. How can the priority approval…
Regulatory Harmonization or Convergence?
Harmonization has long been talked about, but little progress seems to have been made in Africa because of factors including variable geometry, national sovereignty and language…
Education and training
There is very little emphasis in the current pharmacy curricula in pharmalogistics, supply chain management and the attendant regulatory framework and quality management systems. Can short training programmes be developed and how can they be…
Local manufacturing for
local needs
There has been de-industrialization in many African countries with global pharmaceutical companies retreating to global centres of excellence and the entry of Indian…
WHO SHOULD ATTEND
This conference is open to all who have an interest in the pharmaceutical industry in Africa. It will be of particular value to stakeholders in the pharmaceutical industry (human and animal health) , government officials, regulatory authorities, health care workers, non-state actors (NGOs) and researchers.
BENEFITS OF ATTENDING
- Gain new knowledge and information pertaining to global best practices and advice that will help improve individual and business performance.
- Regulatory updates from African Medicine Regulatory Authorities with regards to essential medicines
- Networking opportunities for Peer-to-Peer and Business to Business Engagement